Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Ophthalmology | Family Medicine
View By:YearCompanyConditionsTherapeutic AreasDrug Names
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Approval Status: Approved April 1998
Treatment Area: glaucoma or ocular hypertension
Cosopt has been approved for the reduction of elevated
intraocular pressure in patients with open-angle glaucoma or ocular
hypertension who do not respond adequately to beta-blockers alone.
Both components of Cosopt are leading therapies in their product
categories and are currently available from Merck as individual
medicines under the brand names Trusopt and Timoptic.
In clinical studies, Cosopt administered twice a day produced
reduction in intraocular pressure greater than that seen when
either Trusopt or Timoptic was used as sole therapy. The reduction
was slightly less than that seen when both were used individually
in a concomitant daily treatment regimen of Trusopt three times
daily and Timoptic twice daily.